可吸入的CAR-T细胞衍生外体作为治疗肺癌的帕克利塔塞尔载体
Wei Zheng1, Tianchuan Zhu2, Lantian Tang1
1Center for Infection and Immunity, Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, Guangdong, China.
Journal of translational medicine
|June 12, 2023
概括
携带帕克利塔塞尔 (PTX) 的工程外体向肺瘤,减少大小和毒性. 这种纳米纤维平台增强了非小细胞肺癌 (NSCLC) 的化疗.
科学领域:
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
- 免疫学 免疫学 免疫学
背景情况:
- 非小细胞肺癌 (NSCLC) 是一个重大的全球卫生挑战.
- 帕克利塔塞尔 (PTX) 是一种常见的化疗,但其全身毒性会导致多器官损伤.
- 需要有针对性的输送策略来提高PTX的疗效和减少副作用.
研究的目的:
- 开发一种基于外体的输送系统,用于在肺癌中向输送帕克利塔塞尔 (PTX).
- 在正型肺癌模型中评估PTX载荷的化学抗原受体外体 (PTX@CAR-Exos) 的疗效和毒性.
主要方法:
- 工程T细胞衍生的外体体表达着化抗原受体 (CAR-Exos) 向美索林 (MSLN).
- 封装PTX进入CAR-Exos (PTX@CAR-Exos) 进行吸入输送.
- 利用一个正确的肺癌小鼠模型来评估治疗效果.
主要成果:
- 吸入的PTX@CAR-Exos显示瘤积累,瘤大小减少和延长存活时间.
- 治疗显示最小的全身毒性.
- PTX@CAR-Exos调节了瘤微环境,通过CD8+T细胞透逆转免疫抑制,并增加了IFN-γ和TNF-α水平.
结论:
- 工程外体提供了一个有前途的基于纳米纤维的平台,用于增强化疗.
- 这种策略可以提高药物的疗效,同时尽量减少肺癌治疗中的副作用.
- 该方法为肺癌治疗当前临床挑战提供了潜在的解决方案.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575


